Skip to main content
OTCMKTS:GENSF

Genus Competitors

$66.00
0.00 (0.00 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$66.00
$66.00
50-Day Range
$66.00
$70.40
52-Week Range
$54.00
$77.00
VolumeN/A
Average Volume263 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Genus (OTCMKTS:GENSF) Vs. DDXS, TNGN, ATTBF, ADTX, AGNPF, and LBTSF

Should you be buying GENSF stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Genus, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), ADiTx Therapeutics (ADTX), Algernon Pharmaceuticals (AGNPF), and Almirall (LBTSF).

(DDXS) (OTCMKTS:DDXS) and Genus (OTCMKTS:GENSF) are both health technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares (DDXS) and Genus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
GenusN/AN/AN/A

Earnings & Valuation

This table compares (DDXS) and Genus' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
GenusN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for (DDXS) and Genus, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
Genus01202.67

Summary

Genus beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(TNGN) (OTCMKTS:TNGN) and Genus (OTCMKTS:GENSF) are both health technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Profitability

This table compares (TNGN) and Genus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
GenusN/AN/AN/A

Valuation and Earnings

This table compares (TNGN) and Genus' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
GenusN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for (TNGN) and Genus, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
Genus01202.67

Summary

Genus beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Abattis Bioceuticals (OTCMKTS:ATTBF) and Genus (OTCMKTS:GENSF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Profitability

This table compares Abattis Bioceuticals and Genus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abattis BioceuticalsN/AN/AN/A
GenusN/AN/AN/A

Valuation and Earnings

This table compares Abattis Bioceuticals and Genus' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
GenusN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Abattis Bioceuticals and Genus, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abattis Bioceuticals0000N/A
Genus01202.67

Summary

Genus beats Abattis Bioceuticals on 1 of the 1 factors compared between the two stocks.

ADiTx Therapeutics (NASDAQ:ADTX) and Genus (OTCMKTS:GENSF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Profitability

This table compares ADiTx Therapeutics and Genus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ADiTx TherapeuticsN/AN/AN/A
GenusN/AN/AN/A

Valuation and Earnings

This table compares ADiTx Therapeutics and Genus' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ADiTx TherapeuticsN/AN/AN/AN/AN/A
GenusN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for ADiTx Therapeutics and Genus, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ADiTx Therapeutics00103.00
Genus01202.67

Algernon Pharmaceuticals (OTCMKTS:AGNPF) and Genus (OTCMKTS:GENSF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Algernon Pharmaceuticals and Genus, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Algernon Pharmaceuticals0000N/A
Genus01202.67

Profitability

This table compares Algernon Pharmaceuticals and Genus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Algernon PharmaceuticalsN/AN/AN/A
GenusN/AN/AN/A

Valuation and Earnings

This table compares Algernon Pharmaceuticals and Genus' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Algernon PharmaceuticalsN/AN/AN/AN/AN/A
GenusN/AN/AN/AN/AN/A

Summary

Genus beats Algernon Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

Genus (OTCMKTS:GENSF) and Almirall (OTCMKTS:LBTSF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, institutional ownership and dividends.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Genus and Almirall, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Genus01202.67
Almirall01102.50

Profitability

This table compares Genus and Almirall's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GenusN/AN/AN/A
AlmirallN/AN/AN/A

Earnings & Valuation

This table compares Genus and Almirall's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GenusN/AN/AN/AN/AN/A
AlmirallN/AN/AN/AN/AN/A

Summary

Genus beats Almirall on 2 of the 2 factors compared between the two stocks.


Genus Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Down
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.01flat$0.00N/A0.00Gap Up
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.30flat$0.00N/A0.00Earnings Announcement
Gap Up
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13flat$0.00N/A0.00News Coverage
Gap Down
Almirall logo
LBTSF
Almirall
0.5$15.15flat$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.06flat$0.00N/A0.00
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.00flat$0.00N/A0.00Gap Down
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.67flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.19flat$0.00N/A0.00Gap Up
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Up
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.05flat$0.00N/A0.00
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
Claritas Pharmaceuticals logo
KALTF
Claritas Pharmaceuticals
0.6$0.03flat$0.00N/A0.00Gap Down
CLVLY
Clinuvel Pharmaceuticals
1.0$22.65flat$0.00N/A0.00Gap Up
CELZ
Creative Medical Technology
0.5$0.03flat$0.00N/A0.00News Coverage
Gap Down
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00News Coverage
Gap Up
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.12flat$0.00N/A0.00Gap Down
GB Sciences logo
GBLX
GB Sciences
0.5$0.05flat$0.00N/A0.00News Coverage
Gap Down
Genfit logo
GNFTF
Genfit
0.5$4.17flat$0.00N/A0.00News Coverage
GMXAY
GENMAB A/S/S
0.5$37.08flat$0.00N/A0.00High Trading Volume
HALB
Halberd
0.0$0.03flat$0.00N/A0.00News Coverage
Gap Down
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.63flat$0.00N/A0.00News Coverage
Idorsia logo
IDRSF
Idorsia
0.5$25.00flat$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5N/AN/A$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.19flat$0.00N/A0.00
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00flat$0.00N/A0.00Gap Up
Mesoblast logo
MEOBF
Mesoblast
0.5$1.34flat$0.00N/A0.00
MCURF
Mind Cure Health
0.0$0.27flat$0.00N/A0.00News Coverage
Gap Down
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$3.23flat$0.00N/A0.00Gap Down
Molecular Partners logo
MLLCF
Molecular Partners
0.5$22.48flat$0.00N/A0.00
MorphoSys logo
MPSYF
MorphoSys
0.0$93.05flat$0.00N/A0.00
NRNVF
Nordic Nanovector ASA
0.0$1.64flat$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$74.15flat$0.00N/A0.00Gap Up
BPSR
Organicell Regenerative Medicine
0.5$0.22flat$0.00N/A0.00News Coverage
Gap Up
Oxurion logo
TBGNF
Oxurion
0.5$2.94flat$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.0$3.99flat$0.00N/A0.00
PTEO
Proteo
0.5$0.09flat$0.00N/A0.00
PROT
Proteonomix
0.5$0.02flat$0.00N/A0.00
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.20flat$0.00N/A0.00Gap Up
PureTech Health logo
PTCHF
PureTech Health
0.0$5.24flat$0.00N/A0.00
RCPHF
Recipharm AB (publ)
1.0$16.05flat$0.00N/A0.00High Trading Volume
Regen BioPharma logo
RGBP
Regen BioPharma
0.0N/AN/A$0.00N/A0.00News Coverage
Relief Therapeutics logo
RLFTF
Relief Therapeutics
0.5$0.22flat$0.00N/A0.00News Coverage
Gap Down
BSSP
Reve Technologies
0.0$0.00flat$0.00N/A0.00Gap Up
This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.